Abstract：Objective To evaluate the value of chitinase-like protein YKL-40 in bronchoalveolar lavage fluid (BALF) for predicting refractory Mycoplasma pneumoniae pneumonia (RMPP) in children. Methods A total of 50 children with common Mycoplasma pneumoniae pneumonia (MPP) and 22 children with RMPP were enrolled. The two groups were compared in terms of clinical features, laboratory examination results, imaging findings, and YKL-40 levels in BALF. The receiver operating characteristic (ROC) curve was used to evaluate the value of YKL-40 in BALF for predicting RMPP. Results Compared with the common MPP group, the RMPP group had significantly higher incidence rates of fever, shortness of breath, lung consolidation, and pleural effusion (P < 0.05) and significantly higher serum levels of C-reactive protein and lactate dehydrogenase (P < 0.05). The RMPP group had a significantly higher level of YKL-40 in BALF than the common MPP group (P < 0.05). The ROC curve plotted based on the level of YKL-40 in BALF had an area under the ROC curve of 0.750, a sensitivity of 72.7% and a specificity of 64.0% for predicting RMPP. Conclusions There is an increase in the level of YKL-40 in BALF in children with RMPP, and the level of YKL-40 in BALF has a certain value for predicting RMPP.
HUANG Li-Lin,HUANG Dong-Ping,LU Ling-Long et al. Value of chitinase-like protein YKL-40 in bronchoalveolar lavage fluid for predicting refractory Mycoplasma pneumoniae pneumonia in children[J]. CJCP, 2021, 23(5): 471-474.
Xing Y, Wang D, Sheng K, et al. Dynamic change of Mycoplasma pneumoniae pneumonia in hospitalized children in a general hospital:a 3-year retrospective analysis[J]. Transl Pediatr, 2020, 9(4):522-531.
[2]
Lee H, Yun KW, Lee HJ, et al. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children[J]. Expert Rev Anti Infect Ther, 2018, 16(1):23-34.
[3]
Lee E, Young Lee Y. Risk factors for the development of postinfectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance[J]. Respir Med, 2020, 175:106209.
[4]
Zheng BY, Zhao J, Cao L. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children[J]. BMC Infect Dis, 2020, 20(1):391.
[5]
James A, Stenberg Hammar K, Reinius L, et al. A longitudinal assessment of circulating YKL-40 levels in preschool children with wheeze[J]. Pediatr Allergy Immunol, 2017, 28(1):79-85.
[6]
Lai TW, Wu D, Chen M, et al. YKL-40 expression in chronic obstructive pulmonary disease:relation to acute exacerbations and airway remodeling[J]. Respir Res, 2016, 17:31.
[7]
Yildiz H, Alp HH, Sünnetçioğlu A, et al. Evaluation serum levels of YKL-40, periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma[J]. Heart Lung, 2021, 50(1):177-183.
Tanaka H. Correlation between radiological and pathological findings in patients with Mycoplasma pneumoniae pneumonia[J]. Front Microbiol, 2016, 7:695.
[12]
Cheng SY, Lin JL, Zheng XX, et al. Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children[J]. Pediatr Pulmonol, 2020, 55(4):968-974.
[13]
Zhang YY, Zhou YL, Li SX, et al. The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children[J]. PLoS One, 2016, 11(5):e0156465.
[14]
Liu TY, Lee WJ, Tsai CM, et al. Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children[J]. Pediatr Neonatol, 2018, 59(5):501-506.
[15]
Kusubae R, Nomura Y, Hirabayashi M, et al. β2 microglobulin and lactate dehydrogenase are indices of different features of Mycoplasma pneumoniae-associated community-acquired lower respiratory tract infection for severity evaluation in children[J]. J Infect Chemother, 2019, 25(12):1007-1011.
Lee YC, Chang CH, Lee WJ, et al. Altered chemokine profile in refractory Mycoplasma pneumoniae pneumonia infected children[J]. J Microbiol Immunol Infect, 2020. DOI:10.1016/j.jmii.2020.03.030. Epub ahead of print.
[18]
Choi YJ, Jeon JH, Oh JW. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children:a case control study[J]. Respir Res, 2019, 20(1):193.
[19]
Kang MJ, Yoon CM, Nam M, et al. Role of chitinase 3-like-1 in interleukin-18-induced pulmonary type 1, type 2, and type 17 inflammation; alveolar destruction; and airway fibrosis in the murine lung[J]. Am J Respir Cell Mol Biol, 2015, 53(6):863-871.
